Lower end of treatment HBsAg and HBcrAg were associated with HBsAg loss after nucleos(t)ide analog cessation

Abstract Background Since hepatitis B surface antigen (HBsAg) loss is rarely achieved with nucleos(t)ide analog (NA) treatment, most patients require life-long NA treatment. Previous studies have shown that some patients remain virologically responsive even after NA cessation. However, there is stil...

Descripción completa

Detalles Bibliográficos

Autores principales:	Yandi Xie, Minghui Li, Xiaojuan Ou, Sujun Zheng, Yinjie Gao, Xiaoyuan Xu, Ying Yang, Anlin Ma, Jia Li, Yuemin Nan, Huanwei Zheng, Juan Liu, Lai Wei, Bo Feng
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	BMC 2023-06-01
Colección:	BMC Gastroenterology
Materias:	Nucleos(t)ide analog Cessation Hepatitis B surface antigen Hepatitis B core-related antigen Hepatitis B virus RNA
Acceso en línea:	https://doi.org/10.1186/s12876-023-02852-x
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!